Browsing "1. Journal Papers" by Author : 3519
Showing results 1 to 9 of 9
This table browses all dspace content
| Issue Date | Title | Journal Title |
| 2010 | CYP3A5*3 genotype associated with intrasubject pharmacokinetic variation toward tacrolimus in bioequivalence study | THERAPEUTIC DRUG MONITORING |
| 2011 | Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2012 | Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures | ARCHIVES OF DISEASE IN CHILDHOOD |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2012 | Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
| 2011 | Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study | CLINICAL THERAPEUTICS |
| 2011 | Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants | CLINICAL PHARMACOLOGY & THERAPEUTICS |
| 2012 | The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers | PHARMACOGENETICS AND GENOMICS |
